Author: Paul L. McCormack Lesley J. Scott
Publisher: Adis International
ISSN: 1173-8804
Source: BioDrugs, Vol.18, Iss.5, 2004-01, pp. : 343-347
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Spotlight on Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
By Simpson D. Noble S. Perry C.
BioDrugs, Vol. 17, Iss. 3, 2003-01 ,pp. :
Relapsing-Remitting Multiple Sclerosis: What is the Potential for Combination Therapy?
BioDrugs, Vol. 13, Iss. 3, 2000-03 ,pp. :
Appropriate Use of Interferon Beta-1a in Multiple Sclerosis
By Jacobs L. Brownscheidle C.M.
BioDrugs, Vol. 11, Iss. 3, 1999-03 ,pp. :